Professional Documents
Culture Documents
35 PDF
35 PDF
35 PDF
Review Article
ABSTRACT
Dengue is spreading in urban area with the lightning speed. Dengue is now endemic in more than 100
countries. Dengue disease creates highly complex patho-physiological, economic and ecologic
conditions. Approximately 2.5 billion people live in dengue-risk regions with about 100 million new
cases each year worldwide. Dengue is a public health issue with an economic burden that is currently
challenged for any substantial medicine or vaccination. Considering, the possible positive effects of
papaya leaves in thrombocytopenia occurring in dengue fever, this review highlights the
understanding of dengue and remedy for it.
Key words: Dengue, thrombocytopenia, Carica papaya L., alkaloids, Aedes aegypti.
yet the 1997 WHO classification is still approximately 11 kb in length, has a single
widely used. open reading frame. Reading frame codes
Virology: for three structural and seven structural
Dengue virus (DENV) is a positive- proteins. Structural proteins are capsid,
strand RNA virus of the family Flaviviridae, membrane and envelope glycoproteins.
genus Flavivirus. It exists as four closely Non-structural proteins are NS1, NS2A,
related but anti-genitically distinct serotypes NS2B, NS3, NS4A, NS4B and NS5.
(DENV-1, -2, -3, and -4), all of which have Important biological properties of dengue
Aedes aegypti mosquitoes as their primary viruses, including receptor binding,
vector, with A. albopictus as a secondary haemagglutination of erythrocytes and the
vector. induction of neutralizing antibodies and the
The virion comprises a spherical protective immune response, are associated
particle, 40–50 nm in diameter, with a with the E glycoprotein (Lalla J K 2014).
lipopolysaccharide envelope. The positive
single-strand RNA genome, which is
(Source:http://www.biogents.com/cms/website.php?id=/en/traps/mosquitoes/tiger_mosquitoe s.htm)
provided (Behram M et al, 2015; Bajaj shown a steady rise with every passing year,
A2015; Dengue national guide lines 2015). the mortality has reduced. The overall
World-wide frequency: mortality rate of 1.2% in 2007 dropped to
Some 1.8 billion people are at risk 0.25% in 2013. Compared with the rest of
for dengue worldwide which accounts at South-East Asia, the number of dengue
more than 70%.An estimated 50 million shock syndrome (DSS) cases in India is low
dengue infections occur worldwide (Cecilia D 2014).
annually. An estimated 50,00,00 people Treatment:
with DHF require hospitalization each year. Allopathy- benefits and hazards:
A very large proportion (approximately There is no specific therapy for dengue
90%) of them are children aged less than infections. Good supportive care may be
five years, and about 2.5% of those affected life-saving, but ultimately initiatives aimed
die. Dengue and DHF is endemic in more at vector control and prevention of mosquito
than 100 countries in the WHO regions of bites may provide the greatest benefit
Africa, the Americas, the Eastern (Singhi S et al 2007).
Mediterranean, South-East Asia and the Management of dengue fever is
Western Pacific. The South-East Asia and symptomatic and supportive. Bed rest is
Western Pacific regions are the most advisable during the acute phase. Use
seriously affected. Epidemics of dengue are cold/tepid sponging to keep temperature
increasing in frequency. During epidemics, below 38.5° C. Antipyretics may be used to
infection rates among those who have not lower the body temperature.
been previously exposed to the virus are Aspirin/NSAIDS like Ibuprofen, etc should
often 40% to 50% but can also reach 80% to be avoided since it may cause gastritis,
90%.Seasonal variation is also observed. vomiting, acidosis, platelet dysfunction and
Aedes(Stegomyia) aegypti is the primary severe bleeding.
epidemic vector. Primarily an urban disease, Oral fluid and electrolyte therapy is
dengue and DHF are now spreading to rural recommended for patients with excessive
areas worldwide. Imported cases are sweating or vomiting. Patients should be
common. Co-circulation of multiple monitored for 24 to 48 hours after they
serotypes/genotypes is evident. (WHO become a febrile for development of
2011, 2014) complications (Dengue national guide lines
Status in India: 2015).
When dengue first emerged in India Till now there is no licensed vaccine
during 1950–60s, the disease was mild available against dengue viral infection.
despite circulation of all four serotypes. The Several trials are ongoing in the world for
disease profile changed and greater severity the development of tetravalent dengue
was reported from the late 1980s.The vaccine. So far phase III trials of a
history of dengue outbreaks in India has recombinant, live attenuated tetravalent
been studied. More recent and systematic dengue vaccine (CYD-TDV) has completed
statistics was given by NVBDCP (National in Five Asian countries in children which
vector borne disease control program). Data may be promising in preventing dengue
had shown that dengue has been endemic in infection in near future (Dengue national
16 states since the beginning: Maharashtra, guide lines 2015).
Punjab, Rajasthan, Pondicherry, Kerala, Effective vector control measures
Madhya Pradesh, Delhi, Gujarat, Haryana, are critical to achieve and sustain reduction
Andhra Pradesh, Karnataka, Uttar Pradesh, of morbidity attributable to dengue.
West Bengal, Chandigarh, Goa and Tamil Preventive and vector control interventions
Nadu. During 2010–2012, dengue aim to reduce dengue transmission, thereby
encroached into the remaining states. Even decreasing the incidence of the infection and
though the number of dengue cases has preventing outbreaks of the disease. Attempt
to identify potential antiviral for the The in vitro and in vivo inhibitory
treatment of dengue is a global challenge as potential of aqueous extract of Azidarachta
all four serotypes are frequently undergoing indica (neem) leaves on the replication of
mutations (WHO 2012). virus was evaluated by Parida et al2002.
Studies on herbal medicinal products Turmerone obtained from volatile oil
for platelet augmentation are consistently of Curcuma longa give 100% mosquitocidal
increasing due to the limited supportive activity against Aedes aegypti(Roth et
treatments available for thrombocytopenic al1998).
disorders. The water decoction of leaves from
Plants species traditionally used to treat Euphorbia hirta, locally known as gatas–
dengue fever: gatas, is used in the Philippines as a folk
According to a World Health medicine to treat DF.
Organization (WHO) 80 % of the Efficacy of these species is in
population in some Asian and African following order: P. longum> P.
countries depends on traditional medicine as armentosum Roxb> P ribesoides Wall. This
their primary health care due to economic study conclude that Pepper plant possess
and geographical constraints. Natural activity against Aedes aegypti (U Chaithong
products have become the main source of et al2006).
test material in the development of antiviral Psidium guava is an evergreen shrub
drugs based on traditional medical practices. or small tree indigenous to Mexico, the
Traditional medicinal plants have been Caribbean and Central and South America,
reported to have antiviral activity, and some has been tested in vitro and showed to
have been used to treat viral infections in inhibit the growth of dengue- virus. Water
animals and humans. In the Philippines, boiled with guava leaves has been used to
Euphorbia hirta, known locally as tawa- avoid bleeding in dengue hemorrhagic
tawa, is used in folk medicine to cure fever, and to elevate platelet counts. P.
dengue fever by people in rural areas guava ripe fruit or juice has healing
(Naresh Kumar et al 2015) Andropogon properties in cases of DF by improving the
citratum oil is put in candles and lanterns declining levels of platelets (Abouthealt-
that can be burnt to repel mosquitoes. Its h.com/dengue-fever-medicine 2011).
mosquito repellent qualities have been Carica papaya, Ipomea batatas
verified by research, including effectiveness green and violet variety, Alternanthera
in repelling Aedes aegypti (Gadhwal A et al Sessilis, and Euphorbia hirta have
2016; Ibrahim Jet al,1998). Also there are significant platelet augmentation activity.
many undocumented uses of Euphorbia This is suggestive these plants extracts can
hirta for platelet augmentation probably be used as supportive treatment for
owing to its current prominence in the thrombocytopenic disorders and dengue
Philippines as an alternative supportive hemorrhagic fever which may be an
treatment for dengue hemorrhagic fever. alternative to platelet transfusions (Allorado
This claim is verified by the published et al2010).The investigation on these plant
report (Johnson et al2010) which showed 93.1777% increase in platelet count
demonstrated that there is a significant which corroborated the previous
increase in platelet counts and a decrease in investigation on its effect on blood
bleeding and clotting times in ethanol- components. It is recommended that more
induced thrombocytopenic rats after investigations can be conducted on Ipomea
administration of Euphorbia hirta decoction batatas and Alternanthera Sessilis to further
for 14 days. These folkure medicines need a support the cause (Johnson et al2010).
careful review of other evidences regarding Several Ayurvedic herbs have been
the use of Euphorbia hirta. shown to be effective in treatment of dengue
fever.
probable active components include Global strategy for dengue prevention and
enzymes such aspapain, chymopapain, control(WHO2012)
caspase, alkaloids like carpaine, pseudo- Cecilia D.(2014) Current status of dengue
carpaine and dehydro-carpaine I and II, and chikungunya in India. WHO South-East
flavonoids, benzyl-glucos-inolate and Asia J Public Health; 3(1): 22–27.
tannins, Vitamin B12,C, D, minerals such as Indian Medicinal Plants by Kirtikar KR and
calcium, magnesium, potassium, sodium. Basu BD, Reprint 2nd Edn, International
Book Distributors, Dehradun, II, 1998,
Yet no firm composition responsible to
1097-1099.
resist the disease is presented. The work in Krishna KL, Paridhavi M, Patel JA (2008);
this region is needed in order to explore the Review on nutritional, medicinal and
exact composition of bio-components pharmacological properties of papaya
responsible to raise the platelet count and (Carica papaya Linn.), Natural Product
counter act dengue. Radiance, Vol 7 (4), pp.364-373.
The isolation and purification of the Patil S, Shetty S, Bhide R and Narayanan S
compounds responsible for platelet (2013); Evaluation of Platelet Augmentation
augmentation in the plant would play an Activity of Carica papaya Leaf Aqueous
important role in drug designing for the Extract in Rats Journal of Pharmacognosy
disease. Also study in elucidating the and Phytochemistry. 1(5)57-60.
potential activity of the most probable Gammulle A, Ratnasooriya WD, Jayakody
compound of plants extracts, in mechanism JRAC, Fernando, Kanatiwela C and Preethi
V. Udagama. (2012); Thrombocytosis and
of actionto fight dengue virus at every stage
Anti-inflammatory Properties, and
of lifecycle is needed to be established. In Toxicological Evaluation of Carica papaya
this way building immunity towards natural Mature Leaf Concentrate in a Murine
production of platelet instead of transfer can Model.1 (2)21-30.
be booster against fight for dengue. Hence, Sinhalagoda D, LekamlageChandi A,
the papaya leaf may be a fruitful for Wickramasinghe S, Waduge RN,
research leading to the development of RajapakseP, Jayanthe V, Rajapakse,
herbal therapeutic agent for SenanayakeA, KularatnM(2013); Does
thrombocytopenia and associated Carica papaya leaf-extract increase the
inflammatory disease conditions, manifested platelet count? An experimental study in a
in disease such as dengue. There is also a murine model Asian Pacific Journal of
Tropical Biomedicine Asian Pac J Trop
need to generate awareness and preventive
Biomed 3(9): 720-724.
measures among the people in order to
Benazir F, Gowlikar A, (2015), Therapeutic
control the disease. Combined efforts of the approach for dengue using medicinal plant
health care industries, governing bodies and Carica papaya linn, World Journal of
efforts at individual level would help to Pharmaceutical Research 4(12)607-620
handle the spread of dengue. Behram MRM, Christoph N, Veaceslav B,
and Christian DK,(2015) The Medicinal
REFERENCES Chemistry of Dengue Virus, Journal of
United States Department of Agriculture; Medicinal Chemistry,59, 5622−5649
Natural Resources Conservation Service, Bajaj AH, Yadav KS and Gomes MW,
.http://plants.usda.gov/core/profile?symbol= (2015), Diagnostic and therapeutic
capa23 modalities of dengue fever, World Journal
The wealth of India- A Dictionary Indian of Pharmaceutical Research 5(1), 347-361.
Raw Materials and Products: Raw Material Naresh Kumar CVM, Taranath V,
series, Revised Edn, Vol 3 Ca-Ci Venkatamuni V, Vishnu Vardhan V, Siva
publication and information directorate, Prasad Y, Ravi U and D.V.R. Sai Gopal
CSIR, New (2015)International Journal of Applied
Comprehensive Guidelines for Prevention Biology and Pharmaceutical Technology;
and Control of Dengue and Dengue 6(3),93-96
Haemorrhagic Fever.(WHO 2011)
Kathiresan S, Surash R, Sharif M, Mas Choi ES, Nichol JL, Hokom MM, Hornkohl
Rosemal N, Walther H (2009). AC and Hunt P, (1995) Platelets generated
Thrombocyte counts in mice after the in vitro from proplatelet-displaying human
administration of papaya leaf suspension. megakaryocytes are functional. Blood.; 85:
Wien. Klin. Wochenschr. 121(3): 19-22 402-413
Halim S, Abdullah R, Afzan A, Abdul R, Alva J and Thapar M. Increasing low
Jantan I, Ismail Z (2011). Acute toxicity platelets instantly. WIPO Patent
study of Carica papaya leaf extract in Application; 2010 April. International
Sprague Dawley rats. J. Med. Plants Res. Publication No.: WO-2010/041263; A1.
5:1867-1872. Milind P and Gurditta,(2011) Basketful
Betty A, Wu H, Yu T, Hsuen C (2009). benefits of papaya. International research
Dengue haemorrhage in a mouse model. journal of pharmacy.;2(7) : 6-12
Ann. NY Acad. Sci. 1171: E42-E47. Karim, ABM. Product and method for
Sebastian J, Arie K, Yaohui W, Peter E, treating thrombocytopenia,(2009). [Online]
Oran K, Je H, Shenglin C, Christopher C, Available at:
Anand D, Sudhir K, Mark L(2003). Vitamin http://www.google.com/patents/WO201102
C as an antioxidant: evaluation of its role in 8098A1 [Accessed on 15 Dec., 2013].
disease prevention. J. Am. Coll. Nutr. Patel SR, Hartwig JH and Italiano JE,
22(1):18-35. (2005) the biosynthesis of platelet from
Cabrera-Cortina J, Sanchez-Vakdez E, megakaryocyte proplatelet. J Clin Invest.
Cedas-DeLezama D, Ramirez-Gonzalez M 115: 3348-54.
(2008). Oral calcium administration Songlin P, Xixin ZG, Xinluna W,
attenuates thrombocytopenia in patients Pingchung, L, (2009) Epimedium – derived
with dengue fever, Report of a pilot study. flavonoids promote osteoblastogenesis and
Proc.West. Pharmacol. Soc. 51:38-41. suppress adipogenesis in bone marrow
Jutrat M, Ausaneya S, Harutai T, Thaworn stromal cells while exerting an anabolic
C, Thamrongprawat C, Chitsanu P, Usa T effect on osteoporo- tic bone. Bone; 45:
(2005). Serum and urine sodium levels in 535-44.
dengue patients. The Southeast Asian J. Tahir N, Zaheer Z, Kausar S and Chiragh S,
Trop. Med. Public Health. 36: 197-199. (2014). Prevention Of Fall In Platelet Count
Amitava R, Anil K, Shailendra PV, By Carica papaya Leaf Juice In Carboplatin
Himanshu R, Nirdesh J, (2011). Acute Induced Thrombocytopenia In Sprague
hypokalaemic quadriparesis in dengue dawley rats, Biomedica Vol. 30(1),21-25
fever. BMJ Case Reports. Lalla JK, Ogale S, and Seth S (2014) A
doi:10.1136/bcr.11.2010.3514 Review on Dengue and Treatments
Harmanjith S, Amandeep K, Anuj S, (2012). Research and reviews: journal of
Acute neuromuscular weakness associated pharmacology and toxicological studies.; 2(
with dengue infection. J.Neurosci. Rural 4) 13-24
Pract. 3(1): 36-39. Zunjar V, Jivrajani M, Trivedi B and
Sanjeev J, Ansari M,(2010). Dengue Nivsarkar M, (2016) Antithrombocytopenic
infection causing acute hypokalemic activity of carpaine and alkaloidal extract of
quadriparesis. Neurol. India. 58:592-594 Carica papaya Linn. Leaves in busulfan
Ahn Y, Bymes J, Harrington W, Cayer M, induced thrombocytopenic Wistarrats,
Smith D, Brunskill D, Pall M,(1998) The Journal of Ethnopharmacology 181: 20–25
treatment of idiopathic thrombocytopenia
with Vinblastine-loaded platelets. N Engl J
Med; 298(20):1101-1107.
How to cite this article: Saraf M, Kavimandan B. Dengue fever: role of carica papaya L. Int J
Health Sci Res. 2018; 8(1):249-258.
***********